SOX2 and non-small cell lung carcinoma: Always regarding NSCLCs sensitivity to cisplatin, recently, Cheng and co-workers [111] analyzed the level of sex-determining region Y-box 2 (SOX2) in 45 NSCLC patients’ biopsies and found a direct correlation between SOX2 levels and patients’ outcomes.